Han Wook Choi - Sep 30, 2024 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Chief Financial Officer
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
Sep 30, 2024
Transactions value $
$0
Form type
4
Date filed
10/2/2024, 04:17 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Employee Stock Option (right to buy) Award $0 +400K $0.00 400K Sep 30, 2024 Common Stock 400K $0.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares underlying the option vest on September 30, 2025, with the remainder vesting in equal monthly installments at the end of the each month thereafter over 3 years, in each case subject to the Reporting Person's continued service as of each such date.